¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Corticosteroids And Acetic Acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • phosphoric acid
    Àλê
  • phosphorus acid
    ¾ÆÀλê
  • p-aminobenzoic acid
    ÆÄ¶ó¾Æ¹Ì³ëº¥Á¶»ê
  • p-aminosalicylic acid
    ÆÄ¶ó¾Æ¹Ì³ë»ì¸®½Ç»ê
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • picramic acid
    ÇÇÅ©¶÷»ê
  • pantoic acid
    ÆÇÅä»ê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • propanoic acid
    ÇÁ·ÎÆÇ»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
  • pyruvic acid
    ÇÇ·çºê»ê
  • periodic acid-Schiff stain
    PAS¿°»ö
  • palmitic acid
    ÆÈ¹ÌÆ®»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tricarboxylic acid
    »ïÄ«¸£º¹½Ç»ê
  • trichloroacetic acid
    »ï¿°È­¾Æ¼¼Æ®»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uridine diphosphate glucuronic acid
    ÀÌÀλêÀ¯¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    À¯·ÎÄ«´Ñ»ê
  • uronic acid
    À¯·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµð¿Á½ÃÄݸ°»ê
  • volatile acid
    Èֹ߼º»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
  • tricarboxylic acid cycle
    »ïÄ«¸£º¹½Ç»êȸ·Î
  • nucleic acid hybridization
    ÇÙ»êºÎÇÕÈ­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glutamic acid
    ±Û·çŽ»ê.
  • glutamic acid dehydrogenase
    ±Û·çŽ»êÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çŽ»êµ¥È÷µå·Î°Ô<³ª>Á¦.
  • glutaric acid
    ±Û·çŸ¸£»ê.
  • glyceric acid
    ±Û¸®¼¼¸°»ê(¡­ß«).
  • glyceroboric acid
    ±Û¸®¼¼¸£ºØ»ê
  • glycocholic acid
    ±Û¸®ÄÚÄÝ»ê.
  • glycolic acid
    ±Û¶óÀÌÄÝ»ê
  • gout,uric acid stones
    ¿ä»ê°á¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • time, dose and fractionation factor, TDF factor
    ½Ã°£¼±·®ºÐÇÒÀÎÀÚ
  • to and fro absorbent system
    ¿Õº¹Èí¼ö¹ý.
  • to and fro anesthesia apparatus
    ¿Õº¹½Ä¸¶Ãë±â(èÙÜÖãÒØ«ö­Ðï).
  • to and fro flow
    ÀüÈÄÀ¯µ¿.
  • to and fro method
    ¿Õº¹½Ä(èÙÜÖãÒ).
  • to and fro motion
    ¿Õº¹¿îµ¿.
  • to and fro sound
    ¸¶ÂûÀ½(ؤóÍëå).
  • tooth and nail syndrome
    ÀÌ ¼Õ¹ßÅé ÁõÈıº
  • tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
  • tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
  • trial and error
    ½ÃÇàÂø¿À(ãËú¼ó¹è¦)
  • trial and error
    ½ÃÇàÂø¿À(ãËú¼ó¹è¦).
  • trial-and-error learning
    ½ÃÇàÂø¿ÀÇнÀ(ãËú¼ó¹è¦æßã§).
  • tumor growth,cell cycle and
    ¼¼Æ÷ÁÖ±â¿Í ¡­
  • tumor immunity,gene therapy and
    À¯ÀüÀÚ Ä¡·á¿Í ¡­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • glycocholic acid
    ±Û¶óÀÌÄÚÄÝ»ê(ß«)
  • glycogenic amino acid
    ±Û¶óÀÌÄÚÀü »ý¼º(ßæà÷)¾Æ¹Ì³ë»ê(ß«)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
  • glyconic acid
    ´ç»ê(ÓØß«)
  • glycuronic acid
    ±Û¶óÀÌÅ¥·Ð»ê(ß«)
  • glycyrrhizinic acid
    ±Û¶óÀ̽ø®Áø»ê(ß«)
  • glyoxylic acid reaction
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ¹ÝÀÀ(Úãëë)
  • guanylic acid
    ±¸¾Æ´Ò»ê(ß«)
  • helix-breaking amino acid
    ³ª¼±(Õ¢àÁ) ±ú±â ¾Æ¹Ì³ë»ê(ß«)
  • heterofermentative lactic acid bacteria
    ÀÌÁ¾¹ßÈ¿(ì¶ðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • hexuronic acid
    Çí½´·Ð »ê(ß«)
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
RDDP ribonucleic acid-dependent deoxynucleic acid polymerase
SFA saturated fatty acid; seminal fluid assay; serum folic acid; stimulated fibrinolytic activity; super...
SSA salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr...
TA alkaline tuberculin; arterial tension; axillary temperature; tactile afferent; Takayasu arteritis; t...
tRNA GLU transfer ribonucleic acid glutamic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
ALSPAC Avon Longitudinal Study of Pregnancy and Childhood
BBB Basso, Beattie and Bresnahan
BPSD Behavioral and psychological symptoms of dementia
BWW Biggers Whitten and Whittingham
BEP Bleomycin, etoposide, and cisplatin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • humus acid
    ºÎ½Ä »ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
    ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëµÇ´Â »ê ¿ë¾×.
  • isoniazid : 1. 4-pyridinecarboxylic acid hydrazide. ¹«»ö ¶Ç´Â ¹é»öÀÇ °áÁ¤À̳ª ºÐ¸». °áÇÙ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ³»º¹ ¶Ç´Â ±ÙÀ°¿¡ ÁÖ»çÇÑ´Ù. 2. °áÇÙ±Õ¿¡ ´ëÇÑ È­ÇÐ ¿ä¹ý ¾àÀÇ Çϳª·Î 1Â÷ Ç×°áÇÙÁ¦·Î ¾²ÀδÙ. Àå±â Åõ¿©°¡ µÇ¹Ç·Î ºÎÀÛ¿ë Æ¯È÷ ½Å°æ, ¼ÒÈ­±â Àå¾Ö¿¡ ÁÖÀǸ¦ ¿ä
    µ¿Á¾ µ¶ ¿ä¹ý
    ÁúȯÀÇ »ý»ê¹° ¶Ç´Â ÀÌȯ Àå±â·ÎºÎÅÍ ÃßÃâÇÏ¿© ¸¸µç ¹°Áú·Î ÁúȯÀ» Ä¡·áÇÏ´Â ¹æ¹ý.
  • J acid

    Á¦ÀÌ »ê
    ¿°·áÀÇ Áß°£Ã¼.
  • jalapinolic acid
    ¾â¶óÇdzî»ê
    ÀÌÆ÷¹Ì¾Æ¿¡¼­ ¾ò¾îÁö´Â ¹è´çüÀÇ ¼ººÐ.
  • ketonic acid
    ÄÉÅæ »ê
  • kinotannic acid
    Ű³ëź´Ñ»ê
  • laccainic acid
    ¶óÄ«ÀÎ »ê
    Àû°¥»öÀÇ °áÁ¤ »ê.
  • laccic acid
    ¶óÅ© »ê
    ¶óÅ© ¿°·á¿¡¼­ ¾ò´Â Àû°¥»öÀÇ °áÁ¤¹°.
  • lactic acid
    À¯»ê
    Ä«¸£º¹½Ã±â, ¼ö»ê±â, ¸ÞÆ¿±â, ¼ö¼ÒÀÇ ³× ¿øÀÚ´ÜÀÌ °áÇÕÇÑ ºñ´ëĪ ź¼Ò ¿øÀÚ¸¦ °¡Áö´Â À¯±âÈ­ÇÕ¹°. È÷µå·Ï½Ã ÇÁ·ÎÇǿ»ê, ¶ôÆ®»ê, À¯»êÀ̶ó°íµµ ÇÑ´Ù. 1780³â K.W. ¼Ð·¹¿¡ ÀÇÇØ »êÆÐÇÑ ¿ìÀ¯ ¼Ó¿¡¼­ ¹ß°ßµÇ¾úÀ¸¸ç µ¿½Ä¹°°è¿¡ ³Î¸® Á¸ÀçÇÑ´Ù. D, L, DLÇüÀÇ ±¤ÇÐ À̼ºÁúü°¡ ÀÖ´Ù. L-Á¥»êÀº ÇØ´ç °úÁ¤ÀÇ ÃÖÁ¾ »ê¹°·Î¼­ ÇÇ·çºê»êÀÇ È¯¿ø¿¡ ÀÇÇØ »ý¼ºµÈ´Ù. Á¶ÇؼºÀÌ °­ÇÑ ÁÖ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 25¡­26 ¡ÉÀÌ´Ù. ±ÙÀ°, µ¿¹°Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ¸ç »ç¶÷ÀÇ Ç÷¾× ¼Ó¿¡´Â 100 m§¤´ç 5¡­20 mgÀÌ Á¸ÀçÇϸç, ½ÉÇÑ ¿îµ¿¿¡ ÀÇÇØ Áõ°¡ÇÑ´Ù. ¿îµ¿¿¡ ÀÇÇÑ ±ÙÀ°ÀÇ ÇǷδ ±Û¸®ÄÚ°ÕÀÇ ºÐÇØ¿¡ ÀÇÇÑ L-Á¥»êÀÇ ÃàÀû°ú °ü°è°¡ ÀÖ´Ù. ÈÞ½Ä ½Ã¿¡´Â ±× ÀϺΰ¡ »êÈ­ ºÐÇØµÇÁö¸¸ ´ëºÎºÐ ¿ø·¡ÀÇ ±Û¸®ÄÚ°ÕÀ¸·Î ÀçÇÕ¼ºµÈ´Ù. D-Á¥»êÀº µÎ²¨¿î ÆÇ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 26¡­27 ¡ÉÀÌ´Ù. DL-Á¥»ê
  • lactic acid bacteria
    Á¥»ê ±Õ
    ±Û·çÄÚ¿À½º µî ´ç·ù¸¦ ºÐÇØÇÏ¿© Á¥»êÀ» »ý¼ºÇÏ´Â ¼¼±Õ. ¶ôÆ®»ê±Õ, À¯»ê ±ÕÀ̶ó°íµµ ÇÑ´Ù. Á¥»ê ¹ßÈ¿¿¡ ÀÇÇØ »ý¼ºµÇ´Â Á¥»ê¿¡ ÀÇÇØ¼­ º´¿ø ±Õ°ú À¯ÇØ ¼¼±ÕÀÇ »ýÀ°ÀÌ ÀúÁöµÇ´Â ¼ºÁúÀ» À¯Á¦Ç°
  • lactic acid bacterium
    ¶ôÆ® ±Õ
  • lactic acid formation
    À¯»ê Çü¼º
  • lactonic acid
    ¶ôÅæ »ê
    À¯´ç. ¾Æ¶óºñ¾Æ °í¹«. °¥¶ôÅ佺¸¦ »êÈ­ÇÔÀ¸·Î½á ¾ò¾îÁø´Ù.
  • lanopalmic acid : ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â 1¼ö»ê±â¼ºÀÇ Æ÷È­ Áö¹æ»ê.

    lanosterol

    ¶ó³ë½ºÅ×·Ñ
    ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â ½ºÅ×·ÑÀÇ ÀÏÁ¾.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
schizophrenia and disorders with psychotic features Marked disorders of thought (delusions, hallucinations, or other thought disorder accompanied by disordered affect or behaviour), and deterioration from a previous level of functioning.
(12 Dec 1998)
protoveratrine A and B A mixture of two alkaloids isolated from Veratrum album; they exert their main effect upon the cardiovascular system through the carotid sinus receptors and vagal sensory endings in the heart; they cause vasodilation and are thought to bring about a redistribution to all vascular beds and thus to induce a fall in blood pressure; used in certain forms of hypertension; the maleates have the same actions.
(05 Mar 2000)
psychological phenomena and processes Mechanisms and underlying psychological principles of mental processes and their applications.
(12 Dec 1998)
hoof-and-mouth disease An obsolete term for foot-and-mouth disease.
(05 Mar 2000)
hormones, hormone substitutes, and hormone antagonists A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.
(12 Dec 1998)
sensitivity and specificity Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person.
(12 Dec 1998)
hospital design and construction The architecture, functional design, and construction of hospitals.
(12 Dec 1998)
Hunter and Driffield curve Sensitometric curve of radiographic film, a plot of the film density versus the logarithm of the relative exposure.
Synonym: H and D curve, Hunter and Driffield curve.
(05 Mar 2000)
sexual and gender disorders Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders.
(12 Dec 1998)
sheath of Key and Retzius <anatomy> The delicate bands of connective tissue among nerve fibres.
Origin: NL, fr. Gr. Within + a sinew, nerve.
Source: Websters Dictionary
(01 Mar 1998)
hydroxymethyl and formyl transferases <enzyme> Enzymes that catalyze the transfer of hydroxymethyl or formyl groups.
Registry number: EC 2.1.2
(12 Dec 1998)
short limbs and osteopenia <radiology> Osteogenesis imperfecta, hypophosphatasia
(12 Dec 1998)
signs and symptoms Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).
(12 Dec 1998)
signs and symptoms, digestive Digestive system manifestations of diseases of the gastrointestinal system or of other organs.
(12 Dec 1998)
signs and symptoms, respiratory Respiratory system manifestations of diseases of the respiratory tract or of other organs.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • mild and bitter
    ´Ü¸À ¾´¸ÀÀÌ ¹Ý¹ÝÀÎ ¸ÆÁÖ
  • milk and water
    ±èºüÁø;¸ß¾ø´Â;¸÷½Ã °¨»óÀûÀÎ
  • mix and match
    ±ÕÇüÀÌ ¸ÂÁö ¾Ê´Â °Í ³¢¸®ÀÇ Â¦Áö¿ò
  • nuts and bolts
    (±â°èÀÇ)ÀÛµ¿ºÎ(ºÐ);¿îÀü;°æ¿µ;(»ç¹°ÀÇ)±âº» ¿äÁ¡
  • park-and-ride
    Â÷·Î ¿ª±îÁö °¡¼­ ÁÖÂ÷Çϰí ÀüÂ÷³ª ¹ö½º·Î °¥¾ÆÅ¸´Â (¹æ½Ä)
  • quick and dirty
    (Ä«¿îÅͽÄÀÇ)°£ÀÌ ½Ä´ç(snack bar)
  • rag-and-none man
    ³Õ¸¶ÁÖÀÌ
  • rank-and-file
    Æò»ç¿øÀÇ;(ÁöµµÀÚ°¡ ¾Æ´Ñ)ÀÏ¹Ý Á¶ÇÕ¿øÀÇ;¼­¹Î.ÀÏ¹Ý ´ëÁßÀÇ;(Àå±³°¡ ¾Æ´Ñ)»çº´ÀÇ
  • rank-and-filer
    »çº´;ÀϹݽùÎ;¼­¹Î;Æò»ç¿øµé;Æò´ç¿øµé
  • reach and frequency
    µµ´Þµµ¿Í µµ´Þ Ƚ¼ö(ÀÏ·ÃÀÇ ±¤°í Ȱµ¿À¸·Î ±× °­°í°¡ ¾î´À Á¤µµ ħÅõ Çߴ°¡¸¦ ÃøÁ¤ÇÒ ¶§ »ç¿ëµÇ´Â µÎ°¡Áö ¿ä¼Ò)
  • reaper and binder
    ¹ÙÀδõ(º£¾î¼­ ´Ù¹ßÀ» ¹­´Â ±â°è)
  • research and development
    ¿¬±¸¿Í °³¹ß
  • rest and recuperation
    (º´»çÀÇ)ÈÞ°¡¿Í ÈÞ¾ç
  • rhythm and blues
    ¸®µë ¾Øµå ºí·ç½º(ÈæÀÎ À½¾ÇÀÇ ÀÏÁ¾,rock'n'rollÀÇ ¸ðü)
  • right of visit (and search)
    =RIGHT OF SEARCH
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á